Abstract:CD36 plays a critical role in lipid metabolism, which is closely associated with human immunity. However, the role of CD36 in cancer remains unclear. We performed a pan-cancer analysis to elucidate the potential role of CD36 in cancer by investigating its prognostic value and current predictors for the efficacy of immune checkpoint inhibitors (ICIs) in multiple cancer types. CD36 expression in cancer cell lines, tumor tissue, and their adjacent normal tissues displayed heterogeneity among different cancers. Immunohistochemistry was used to detect CD36 expression and confirmed the results. CD36 expression significantly affects prognosis in the six cancer types. High CD36 expression was marginally associated with poorer prognosis in four of them and improved prognosis in the remaining two types. CD36 expression was significantly correlated with the 6 immune infiltrates in most cancer types. In addition, CD36 gene expression was positively correlated with Stromal score, Immune score, and ESTIMATE score. A total of 47 immune checkpoint genes were collected and their relationship with CD36 expression was analyzed. CD36 expression was significantly associated with multiple stimulatory and inhibitory checkpoint molecules with a disease-specific pattern. As to the genes reported to positively relate to the efficacy of ICIs, CD36 expression was positively correlated with most of them but negatively associated with a small proportion of cancer type-specific patterns. Concerning the genes negatively related to the efficacy of ICIs, CD36 expression was positively correlated with NRP1 and TNFSF15 in multiple cancers. CD36 expression was negatively correlated with tumor neoantigen burden in most cancer types. However, CD36 expression was negatively correlated with tumor mutation burden in most cancer types. The correlation between CD36 expression and the four methyltransferases was also significant in multiple cancers, but also with a cancer type-specific pattern. In summary, the current study found CD36 expression and its prognostic value in multiple cancer types. In addition, the expression of CD36 was significantly associated with current predictors for the efficacy of ICIs. The practical application value of CD36 is disease specific.

CD36: the Bridge Between Lipids and Tumors

CD36 and Its Role in Regulating the Tumor Microenvironment

CD36 Tango in Cancer: Signaling Pathways and Functions

Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression

Ligand-dependent CD36 Functions in Cancer Progression, Metastasis, Immune Response, and Drug Resistance

Cancer-associated Fibroblasts Contributed to Hepatocellular Carcinoma Recurrence and Metastasis Via CD36-mediated Fatty-Acid Metabolic Reprogramming.

CD36-mediated Metabolic Crosstalk Between Tumor Cells and Macrophages Affects Liver Metastasis

Fatty acid-induced CD36 expression via O-GlcNAcylation drives gastric cancer metastasis.

The activated CD36-Src axis promotes lung adenocarcinoma cell proliferation and actin remodeling-involved metastasis in high-fat environment

Down-expression of CD36 in Pancreatic Adenocarcinoma and Its Correlation with Clinicopathological Features and Prognosis.

CD 36: Focus on Epigenetic and Post-Transcriptional Regulation

The fatty acid receptor CD36 promotes macrophage infiltration via p110γ signaling to stimulate metastasis

Unravelling the role of obesity and lipids during tumor progression

CD39 Transforming Cancer Therapy by Modulating Tumor Microenvironment

The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis

Prognostic and immunological role of CD36: A pan-cancer analysis

Upregulation of CD36, a Fatty Acid Translocase, Promotes Colorectal Cancer Metastasis by Increasing MMP28 and Decreasing E-Cadherin Expression

CD36 Initiates Src Signal Transduction to Promote Actin Remodeling-Involved Metastasis of Lung Adenocarcinoma in High-Fat Environment

Characterization of the Fatty Acid Metabolism in Colorectal Cancer to Guide Clinical Therapy

Aberrant lipid metabolism in cancer cells and tumor microenvironment: the player rather than bystander in cancer and metastasis

CD36 Plays a Critical Role in Proliferation, Migration and Tamoxifen-Inhibited Growth of ER-positive Breast Cancer Cells